Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Oct;32(4):508–511. doi: 10.1111/j.1365-2125.1991.tb03940.x

Further insight into the stereoselective interaction between warfarin and cimetidine in man.

I Niopas 1, S Toon 1, M Rowland 1
PMCID: PMC1368615  PMID: 1958448

Abstract

The urinary profile of R- and S-warfarin, following administration of a single (25 mg) oral dose of racemic warfarin, alone or on day 4 of a 9-day chronic administration of cimetidine (800 mg once daily), was investigated in eight healthy male volunteers. Based on estimated apparent formation clearance values, cimetidine inhibited significantly only the formation of R-6-hydroxywarfarin and R-7-hydroxywarfarin.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banfield C., O'Reilly R., Chan E., Rowland M. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. Br J Clin Pharmacol. 1983 Dec;16(6):669–675. doi: 10.1111/j.1365-2125.1983.tb02239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Banfield C., Rowland M. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. J Pharm Sci. 1984 Oct;73(10):1392–1396. doi: 10.1002/jps.2600731017. [DOI] [PubMed] [Google Scholar]
  3. Bauman J. H., Kimelblatt B. J. Cimetidine as an inhibitor of drug metabolism: therapeutic implications and review of the literature. Drug Intell Clin Pharm. 1982 May;16(5):380–386. doi: 10.1177/106002808201600504. [DOI] [PubMed] [Google Scholar]
  4. Bell J. A., Gower A. J., Martin L. E., Mills E. N., Smith W. P. Interaction of H2-receptor antagonists with drug-metabolizing enzymes. Biochem Soc Trans. 1981 Feb;9(1):113–114. doi: 10.1042/bst0090113. [DOI] [PubMed] [Google Scholar]
  5. Breckenridge A., Orme M. Kinetics of warfarin absorption in man. Clin Pharmacol Ther. 1973 Nov-Dec;14(6):955–961. doi: 10.1002/cpt1973146955. [DOI] [PubMed] [Google Scholar]
  6. Bush E., Trager W. F. High-yield synthesis of warfarin and its phenolic metabolites: new compounds. J Pharm Sci. 1983 Jul;72(7):830–831. doi: 10.1002/jps.2600720732. [DOI] [PubMed] [Google Scholar]
  7. Chan K. K., Lewis R. J., Trager W. F. Absolute configurations of the four warfarin alcohols. J Med Chem. 1972 Dec;15(12):1265–1270. doi: 10.1021/jm00282a016. [DOI] [PubMed] [Google Scholar]
  8. Choonara I. A., Cholerton S., Haynes B. P., Breckenridge A. M., Park B. K. Stereoselective interaction between the R enantiomer of warfarin and cimetidine. Br J Clin Pharmacol. 1986 Mar;21(3):271–277. doi: 10.1111/j.1365-2125.1986.tb05190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Collen M. J., Howard J. M., McArthur K. E., Raufman J. P., Cornelius M. J., Ciarleglio C. A., Gardner J. D., Jensen R. T. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med. 1984 Jan;100(1):52–58. doi: 10.7326/0003-4819-100-1-52. [DOI] [PubMed] [Google Scholar]
  10. Freston J. W. Cimetidine. I. Developments, pharmacology, and efficacy. Ann Intern Med. 1982 Oct;97(4):573–580. doi: 10.7326/0003-4819-97-4-573. [DOI] [PubMed] [Google Scholar]
  11. Hermodson M. A., Barker W. M., Link K. P. Studies on the 4-hydroxycoumarins. Synthesis of the metabolites and some other derivatives of warfarin. J Med Chem. 1971 Feb;14(2):167–169. doi: 10.1021/jm00284a022. [DOI] [PubMed] [Google Scholar]
  12. Hetzel D. J., Bochner F., Hallpike J. F., Shearman D. J., Hann C. S. Cimetidine interaction with phenytoin. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1512–1512. doi: 10.1136/bmj.282.6275.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaminsky L. S., Dunbar D. A., Wang P. P., Beaune P., Larrey D., Guengerich F. P., Schnellmann R. G., Sipes I. G. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab Dispos. 1984 Jul-Aug;12(4):470–477. [PubMed] [Google Scholar]
  14. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  15. Lewis R. J., Trager W. F., Chan K. K., Breckenridge A., Orme M., Roland M., Schary W. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest. 1974 Jun;53(6):1607–1617. doi: 10.1172/JCI107711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lewis R. J., Trager W. F. The metabolic fate of warfarin: studies on the metabolites in plasma. Ann N Y Acad Sci. 1971 Jul 6;179:205–212. doi: 10.1111/j.1749-6632.1971.tb46900.x. [DOI] [PubMed] [Google Scholar]
  17. Sedman A. J. Cimetidine-drug interactions. Am J Med. 1984 Jan;76(1):109–114. doi: 10.1016/0002-9343(84)90758-7. [DOI] [PubMed] [Google Scholar]
  18. Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
  19. Somogyi A., Gugler R. Drug interactions with cimetidine. Clin Pharmacokinet. 1982 Jan-Feb;7(1):23–41. doi: 10.2165/00003088-198207010-00002. [DOI] [PubMed] [Google Scholar]
  20. Toon S., Hopkins K. J., Garstang F. M., Aarons L., Sedman A., Rowland M. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects. Clin Pharmacol Ther. 1987 Jul;42(1):33–41. doi: 10.1038/clpt.1987.104. [DOI] [PubMed] [Google Scholar]
  21. Toon S., Hopkins K. J., Garstang F. M., Rowland M. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur J Clin Pharmacol. 1987;32(2):165–172. doi: 10.1007/BF00542190. [DOI] [PubMed] [Google Scholar]
  22. Toon S., Low L. K., Gibaldi M., Trager W. F., O'Reilly R. A., Motley C. H., Goulart D. A. The warfarin-sulfinpyrazone interaction: stereochemical considerations. Clin Pharmacol Ther. 1986 Jan;39(1):15–24. doi: 10.1038/clpt.1986.3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES